Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study

Abstract Interstitial lung disease (ILD) leads to worse outcomes in subjects with rheumatoid arthritis (RA). Few large-scale longitudinal studies have provided comprehensive data on the incidence and risk of ILD in RA compared with non-RA populations. We compare the risk of incident ILD in subjects...

Full description

Saved in:
Bibliographic Details
Main Authors: Bo-Guen Kim, Hyun Lee, Yeonghee Eun, Kyungdo Han, Jin-Hyung Jung, Hayoung Choi, Hyungjin Kim, Dong Wook Shin
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-88323-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850087295530565632
author Bo-Guen Kim
Hyun Lee
Yeonghee Eun
Kyungdo Han
Jin-Hyung Jung
Hayoung Choi
Hyungjin Kim
Dong Wook Shin
author_facet Bo-Guen Kim
Hyun Lee
Yeonghee Eun
Kyungdo Han
Jin-Hyung Jung
Hayoung Choi
Hyungjin Kim
Dong Wook Shin
author_sort Bo-Guen Kim
collection DOAJ
description Abstract Interstitial lung disease (ILD) leads to worse outcomes in subjects with rheumatoid arthritis (RA). Few large-scale longitudinal studies have provided comprehensive data on the incidence and risk of ILD in RA compared with non-RA populations. We compare the risk of incident ILD in subjects with RA and matched controls, while also evaluating the impact of RA serologic status. Using the Korean National Health Insurance Service Data between 2010 and 2017, we identified 52,325 individuals with RA and 261,625 without RA. During a median follow-up period of 4.4 years, 3.7% of the RA cohort and 0.5% of the matched cohort developed ILD, with incidence rates of 8.30 and 1.01 per 1,000 person-years. Compared to controls, the risk of incident ILD was significantly higher in the RA cohort (adjusted hazard ratio [aHR] 7.84 [7.29–8.44]), and seropositive and seronegative RA exhibited aHRs of 9.00 (8.34–9.72) and 4.81 (4.25–5.44). Although the risk of ILD was higher in seropositive RA than seronegative RA, the risk of developing ILD was also higher in subjects with seronegative RA than in matched controls, suggesting that close monitoring for ILD should be performed in this population.
format Article
id doaj-art-206d0933c7524db6aa44a3d5b8116d4b
institution DOAJ
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-206d0933c7524db6aa44a3d5b8116d4b2025-08-20T02:43:15ZengNature PortfolioScientific Reports2045-23222025-02-0115111110.1038/s41598-025-88323-7Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal studyBo-Guen Kim0Hyun Lee1Yeonghee Eun2Kyungdo Han3Jin-Hyung Jung4Hayoung Choi5Hyungjin Kim6Dong Wook Shin7Division of Pulmonary Medicine, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of MedicineDivision of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of MedicineDivision of Rheumatology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of MedicineDepartment of Statistics and Actuarial Science, Soongsil UniversitySamsung Biomedical Research Institute, Sungkyunkwan University School of MedicineDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of MedicineDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of MedicineDepartment of Family Medicine & Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of MedicineAbstract Interstitial lung disease (ILD) leads to worse outcomes in subjects with rheumatoid arthritis (RA). Few large-scale longitudinal studies have provided comprehensive data on the incidence and risk of ILD in RA compared with non-RA populations. We compare the risk of incident ILD in subjects with RA and matched controls, while also evaluating the impact of RA serologic status. Using the Korean National Health Insurance Service Data between 2010 and 2017, we identified 52,325 individuals with RA and 261,625 without RA. During a median follow-up period of 4.4 years, 3.7% of the RA cohort and 0.5% of the matched cohort developed ILD, with incidence rates of 8.30 and 1.01 per 1,000 person-years. Compared to controls, the risk of incident ILD was significantly higher in the RA cohort (adjusted hazard ratio [aHR] 7.84 [7.29–8.44]), and seropositive and seronegative RA exhibited aHRs of 9.00 (8.34–9.72) and 4.81 (4.25–5.44). Although the risk of ILD was higher in seropositive RA than seronegative RA, the risk of developing ILD was also higher in subjects with seronegative RA than in matched controls, suggesting that close monitoring for ILD should be performed in this population.https://doi.org/10.1038/s41598-025-88323-7Rheumatoid arthritisInterstitial lung diseaseEpidemiologyRisk
spellingShingle Bo-Guen Kim
Hyun Lee
Yeonghee Eun
Kyungdo Han
Jin-Hyung Jung
Hayoung Choi
Hyungjin Kim
Dong Wook Shin
Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study
Scientific Reports
Rheumatoid arthritis
Interstitial lung disease
Epidemiology
Risk
title Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study
title_full Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study
title_fullStr Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study
title_full_unstemmed Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study
title_short Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study
title_sort association between rheumatoid arthritis and interstitial lung disease and impact of serologic status a large scale longitudinal study
topic Rheumatoid arthritis
Interstitial lung disease
Epidemiology
Risk
url https://doi.org/10.1038/s41598-025-88323-7
work_keys_str_mv AT boguenkim associationbetweenrheumatoidarthritisandinterstitiallungdiseaseandimpactofserologicstatusalargescalelongitudinalstudy
AT hyunlee associationbetweenrheumatoidarthritisandinterstitiallungdiseaseandimpactofserologicstatusalargescalelongitudinalstudy
AT yeongheeeun associationbetweenrheumatoidarthritisandinterstitiallungdiseaseandimpactofserologicstatusalargescalelongitudinalstudy
AT kyungdohan associationbetweenrheumatoidarthritisandinterstitiallungdiseaseandimpactofserologicstatusalargescalelongitudinalstudy
AT jinhyungjung associationbetweenrheumatoidarthritisandinterstitiallungdiseaseandimpactofserologicstatusalargescalelongitudinalstudy
AT hayoungchoi associationbetweenrheumatoidarthritisandinterstitiallungdiseaseandimpactofserologicstatusalargescalelongitudinalstudy
AT hyungjinkim associationbetweenrheumatoidarthritisandinterstitiallungdiseaseandimpactofserologicstatusalargescalelongitudinalstudy
AT dongwookshin associationbetweenrheumatoidarthritisandinterstitiallungdiseaseandimpactofserologicstatusalargescalelongitudinalstudy